WG
GILD icon

Winchester Group’s Gilead Sciences GILD Stock Holding History

Winchester Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.11M Hold
17,600
– – 0.24% 101
2013
Q2 		$902K Buy
+17,600
New +$917K 0.19% 114

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Winchester Group's GILD Position: Q3 2013 in Review

Winchester Group held its Gilead Sciences (GILD) position steady in Q3 2013 at 17,600 shares worth $1.11M. The position accounts for 0.24% of the portfolio, ranked #101.

Winchester Group first reported a position in GILD in Q2 2013 and has held it in 2 quarters since. 982 funds tracked by Wall St. Rank hold GILD as of Q3 2013.

  • Winchester Group held 17,600 shares of Gilead Sciences worth $1.11M as of Q3 2013.
  • Winchester Group left its Gilead Sciences share count unchanged in Q3 2013.
  • Gilead Sciences made up 0.24% of Winchester Group's portfolio in Q3 2013, its #101 holding.
  • Winchester Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 2 quarters since.
  • 982 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2013.

Based on Winchester Group's 13F filing for Q3 2013, filed 16 Oct 2013.